Epidemiology and prevention of Staphylococcus aureus nasal carriage in hemodialyzed patients

Medecine et Maladies Infectieuses

Volumn 41, Issue 9, 2011, Pages 469-474

  Souly, K ^a   Ait El kadi, M ^a   Lahmadi, K ^a   Biougnach, H ^a   Boughaidi, A ^a   Zouhdi, M ^a   Benasila, S ^a   Elyoussefi, Z ^a   Bouattar, T ^a   Zbiti, N ^a   Skalli, Z ^a   Rhou, H ^a   Ouzeddoun, N ^a   Bayahia, R ^a   Benamar, L ^a  

^a IBN SINA HOSPITAL   (Morocco)

Author keywords

Hemodialysis; Mupirocin; Nasal carriage; Staphylococcus aureus

Indexed keywords

PSEUDOMONIC ACID;

ADULT; ARTICLE; BACTERIUM CARRIER; BACTERIUM IDENTIFICATION; CLINICAL ARTICLE; CLINICAL PROTOCOL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; INFECTION CONTROL; INFECTION PREVENTION; INFECTION RISK; MALE; MASS SCREENING; MOROCCO; SEX RATIO; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; TREATMENT DURATION;

ADMINISTRATION, INTRANASAL; ADULT; ANTI-BACTERIAL AGENTS; CARRIER STATE; COMORBIDITY; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; KIDNEY FAILURE, CHRONIC; MALE; MASS SCREENING; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE AGED; MOROCCO; MUPIROCIN; NASAL CAVITY; PREVALENCE; RENAL DIALYSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 80053050707     PISSN: 0399077X     EISSN: 17696690     Source Type: Journal    
DOI: 10.1016/j.medmal.2011.05.005     Document Type: Article

References (32)

1. Koziol-Montewka M., Szczepanik A., Baranowicz I., Jozwiak L., Ksiazek A., Kaczor D. The investigation of Staphylococcus aureus and coagulase-negative staphylococci nasal carriage among patients undergoing haemodialysis. Microbiol Res 2006, 161:281-287.
2. Kozioł-Montewka M., Chudnicka A., Ksiazek A., Majdan M. Rate of Staphylococcus aureus nasal carriage in immunocompromised patients receiving haemodialysis treatment. Int J Antimicrob Agents 2001, 18:193-196.
3. Forestier E., Rémy V., Mohseni-Zadeh M., Lesens O., Jauhlac B., Christmann D., et al. Bactériémies à Staphylococcus aureus résistant à la méthicilline: aspects épidémiologiques et thérapeutiques récents. Rev Med Interne 2007, 28:746-755.
4. Hoen B., Domart Y., Cartier F., Etienne J., Goeau-Brissonniere O., Voiriot P., et al. Infections liées à l'abord vasculaire chez l'hémodialysé chronique. Propositions thérapeutiques. Med Mal Infect 1992, 22(supp 1):366-369.
5. Wertheim H.F.L., Melles D.C., Vos M.C., van Leeuwen W., van Belkum A., Verbrugh H.A., et al. The role of nasal carriage in Staphylococcus aureus infections. Lancet Infect Dis 2005, 5:751-762.
6. Edoh V., Gadou D., Tia H., Gnonsahe D. Épidémiologie et prévention du portage nasal de Staphylococcus aureus chez les malades et le personnel du centre d'hémodialyse de Cocody-Abidjan. Med Trop 2003, 63:590-592.
7. Kozioł-Montewka M., Chudnicka A., Ksiazek A., Majdan M. Rate of Staphylococcus aureus nasal carriage in immunocompromised patients receiving haemodialysis treatment. Int J Antimicrob Agents 2001, 18:193-196.
8. Johan R., Boelaert, et al. Épidémiologie et prévention des infections à Staphylococcus aureus en hémodialyse. Néphrologie 1994, 15:157-161.
9. Nguyen Van a J.-C., Kitzis M.-D., Ly A., Chalfine A., Carlet J., Ben Ali A., et al. Détection de la colonisation nasale de Staphylococcus aureus résistant à la méthicilline: étude prospective comparant l'amplification génique temps réel vs les milieux chromogènes sélectifs. Pathol Biol 2006, 54:285-292.
10. Askarian M., Zeinalzadeh A., Japoni A., Alborzi A., Memish Z.A. Prevalence of nasal carriage of methicillin-resistant Staphylococcus aureus and its antibiotic susceptibility pattern in healthcare workers at Namazi Hospital, Shiraz, Iran. Int J Infect Dis 2009, 13:241-247.
11. Safdar N., Bradley E.A. The risk of infection after nasal colonization with Staphylococcus aureus. Am J Med 2008, 121:310-315.
12. Kikuchi K., et al. Selective medium for screening for mupirocin-resistant staphylococci. J Clin Pathol 1998, 46:91.
13. Critchley I.A. Eradication of MRSA nasal colonization as a strategy for infection prevention. J Infect Dis 2006, 3:189-195.
14. Lucet J.C. The importance of detecting methicillin-resistant Staphylococcus aureus in an intensive care setting. Ann Fr Anesth Reanim 2002, 21:384-391.
15. Holton D.L., et al. Efficacy of mupiricin nasal ointment in eradicating Staphylococcus aureus carriage in chronic haemodialysis patients. J Hosp Infect 1991, 17:133-137.
16. Montagnac R., Eloy C., Schillinger F., Croix L.C., Milcent T. Étude itérative de la prévalence du portage nasal de Staphylococcus aureus chez l'hémodialysé. Presse Med 1995, 24(23):1075-1077.
17. Ternois I., Geffroy S., Brun Y., Lemeland J.F., Etienne I., Fleurette J., et al. Évaluation du portage de Staphylococcus aureus chez les maladies et le personnel d'un centre d'hémodialyse en vue de la prévention des infections. Pathol Biol 1993, 41(4):428-433.
18. Muro K., Lim P.B. A comparison of mupirocin and rifampin in short terme radication of Staphylococcus aureus nasal carriage in hemodialysis patients. J Am Soc Nephrol 1991, 2:340.
19. Pena C., Fernandez-Sabe N., Dominguez M.A., Pujol M., Martinez-Castelao A., Ayats J., et al. Staphylococcus aureus nasal carriage in patients on haemodialysis: role of cutaneous colonization. J Hosp Infect 2004, 58:20-27.
20. Boelaert J.R., et al. S. aureus infection in haemodialysis patients: pathophysiology and use of nasal mupirocine for prevention. J Chemother 1995, 7:49-53.
21. Glowacki L.S., Hodsman A.B., Hammerberg O., Meraw J., McNeill V., Card M.L., et al. Surveillance and prophylactic intervention of Staphylococcus aureus nasal colonization in a hemodialysis unit. Am J Nephrol 1994, 14:9-13.
22. Watanakunakorn C., Brandt J., Purkin P., Santore S., Bota B., Stahl C.J. The efficacy of mupirocine ointment and chlorexidine body scrubs in the eradication of Staphylococcus aureus among patients undergoing long-term haemodialysis. Am J Infect Control 1992, 20:138-141.
23. Kirmani N., Tuazon C.U., Muray H.W., Parrish A.E., Sheagren J.N. Staphylococcus aureus carriage rate of patients receiving long-term haemodialysis. Arch Intern Med 1978, 138:1657-1659.
24. Cattoen C., Lemaitre V., Bouillet L., Gobert P., Berrouane Y., Chatelain C., et al. Infections à Staphylococcus aureus chez l'hémodialysé et portage nasal. Utilisation de la mupirocine. Med Mal Inf 1994, 24:668-673.
25. Kresken M., Hafner D., Schmitz F.-J., Wichelhaus T.A. Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the antimicrobial resistance surveillance study of the Paul-Ehrlich-Society for chemotherapy, 2001. Int J Antimicrob Agents 2004, 23:577-581.
26. Boelaert J.R., De Baere Y.A., Geernaert M.A., Godard C.A., Van Landuyt H.W. The use of nasal mupirocin ointment to prevent Staphylococcus aureus bacteraemias in haemodialysis patients: an analysis of cost-effectiveness. J Hosp Infect 1991, 19(Suppl B):41-46.
27. Boelaert J.R., et al. The influence of calcium mupirocin nasal ointment on the incidence of Staphylococcus aureus infections in heamodialysis patients. Nephrol Dial Transplant 1989, 4:278-281.
28. Boelart J.R., et al. Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemia in heamodialysis patients. Nephrol Dial Transplant 1993, 8:235-239.
29. Peacock S.J., Mandal S., Bowler I.C.J.W. Preventing Staphylococcus aureus infection in the renal unit. Q J Med 2002, 95:405-410.
30. Kluytmans J.A., Manders M.J., van Bommel E., Verbrugh H. Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996, 17:793-797.
31. Loveday H.P., Pellowe C.M., Jones S.R.L.J., Pratt R.J. A systematic review of the evidence for interventions for the prevention and control of meticillin-resistant Staphylococcus aureus (1996-2004): report to the joint MRSA working party (Subgroup A). J Hosp Infect 2006, 63:45-70.
32. Uehara Y., Nakama H., Agematsu K., Uchida M., Kawakami Y., Abdul Fattah A.S.M., et al. Bacterial interference among nasal inhabitants: eradication of Staphylococcus aureus from nasal cavities by artificial implantation of Corynebacterium sp. J Hosp Infect 2000, 44:127-133.